Bendeka (bendamustine hydrochloride injection) is prescribed to treat chronic lymphocytic leukemia and a type of lymphoma. The drug comes as a solution that you receive by infusion into a vein for a ...
Before you start treatment with Bendeka, tell your doctor and pharmacist which prescription, over-the-counter, and other medications you take. By sharing this information with them, you may help ...
Bendeka (bendamustine) can cause side effects that range from mild to serious. More common side effects include anemia and thrombocytopenia. If side effects from Bendeka become difficult to tolerate, ...
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has granted seven years of ...
In the first quarter of 2016, Teva Pharmaceutical Industries (TEVA) launched a new drug, Bendeka, in partnership with Eagle Pharmaceuticals. The new drug is expected to allow Teva to maintain its ...
Eagle has reached a settlement agreement with Dr. Reddy’s. Eagle had asserted its Orange Book-listed patents against Dr. Reddy’s related to its new drug application referencing Bendeka. Bendeka is ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a low-volume bendamustine hydrochloride injection for the treatment of patients with chronic ...
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the "Company" or "Eagle") today announced that it has entered into a royalty purchase agreement ...
WOODCLIFF LAKE, N.J., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has reached a settlement agreement with Accord ...
Wednesday, FDA released a letter stating how the agency intends to implement the scope of orphan drug exclusivity awarded to Eagle Pharmaceuticals’ Bendeka (bendamustine HCl) by the D.C. Circuit Court ...
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has denied Eagle’s request ...
In the first quarter of 2016, Teva Pharmaceutical Industries (TEVA) launched a new drug, Bendeka, in partnership with Eagle Pharmaceuticals. The new drug is expected to allow Teva to maintain its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results